[HTML][HTML] Dengue virus infection–a review of pathogenesis, vaccines, diagnosis and therapy
The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human,
causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar …
causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar …
[HTML][HTML] Recent advances in antiviral drug development towards dengue virus
B Troost, JM Smit - Current opinion in virology, 2020 - Elsevier
Highlights•Evaluating drug efficacy, specificity and toxicity may help to develop an optimal
treatment regime for in vivo studies.•Measuring time to resolve viremia in vivo may help to …
treatment regime for in vivo studies.•Measuring time to resolve viremia in vivo may help to …
Molecular mechanisms of antiviral agents against dengue virus
Dengue is a major global health threat causing 390 million dengue infections and 25,000
deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of …
deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of …
Updates on dengue vaccine and antiviral: where are we heading?
H Norshidah, R Vignesh, NS Lai - Molecules, 2021 - mdpi.com
Approximately 100–400 million people from more than 100 countries in the tropical and
subtropical world are affected by dengue infections. Recent scientific breakthroughs have …
subtropical world are affected by dengue infections. Recent scientific breakthroughs have …
The medicinal chemistry of dengue virus
MAM Behnam, C Nitsche, V Boldescu… - Journal of medicinal …, 2016 - ACS Publications
The dengue virus and related flaviviruses are an increasing global health threat. In this
perspective, we comment on and review medicinal chemistry efforts aimed at the prevention …
perspective, we comment on and review medicinal chemistry efforts aimed at the prevention …
Anti-dengue infectivity evaluation of bioflavonoid from Azadirachta indica by dengue virus serine protease inhibition
Dengue virus (DENV) serine protease enzyme, ie NS2B-NS3pro (non-structural protein 2B-
non-structural protein 3) has been approved as prime drug target for the drug discovery …
non-structural protein 3) has been approved as prime drug target for the drug discovery …
Antimicrobial peptides and their potential application in antiviral coating agents
ED Freitas, RA Bataglioli, J Oshodi… - Colloids and Surfaces B …, 2022 - Elsevier
Coronavirus pandemic has evidenced the importance of creating bioactive materials to
mitigate viral infections, especially in healthcare settings and public places. Advances in …
mitigate viral infections, especially in healthcare settings and public places. Advances in …
[HTML][HTML] Peptides as therapeutic agents for dengue virus
MF Chew, KS Poh, CL Poh - International journal of medical …, 2017 - ncbi.nlm.nih.gov
Dengue is an important global threat caused by dengue virus (DENV) that records an
estimated 390 million infections annually. Despite the availability of CYD-TDV as a …
estimated 390 million infections annually. Despite the availability of CYD-TDV as a …
Dengue virus: pathogenesis and potential for small molecule inhibitors
N Chauhan, KK Gaur, TR Asuru… - Bioscience reports, 2024 - portlandpress.com
Dengue, caused by dengue virus (DENV), is now endemic in nearly 100 countries and
infection incidence is reported in another 30 countries. Yearly an estimated 400 million …
infection incidence is reported in another 30 countries. Yearly an estimated 400 million …
Dengue virus and its inhibitors: a brief review
The global occurrence of viral infectious diseases poses a significant threat to human health.
Dengue virus (DENV) infection is one of the most noteworthy of these infections. According …
Dengue virus (DENV) infection is one of the most noteworthy of these infections. According …